Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Gilead-Sciences
Company Monitoring Page for Gilead-Sciences
latest headlines for company on cafepharma
Gilead can't escape antitrust suit centered on pay-for-delay deal with Cipla, judge says
Fierce Pharma
Tue, 08/23/22 - 10:24 pm
Tags:
Gilead Sciences
,
Cipla
,
pay-for-delay
,
legal generics
,
Emtriva
,
Viread
After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights
Fierce Pharma
Tue, 08/16/22 - 12:36 pm
Tags:
Gilead Sciences
,
Immunomedics
,
Trodelvy
,
Everest Medicines
How a small UK biotech ended up in Gilead’s hands
BioPharma Dive
Sun, 08/7/22 - 11:18 pm
Tags:
Gilead Sciences
,
MiroBio
,
M&A
,
University of Oxford
Gilead Sciences to acquire Oxford University biotech spinout MiroBio for $405M
TechCrunch
Thu, 08/4/22 - 06:41 pm
Tags:
Gilead Sciences
,
M&A
,
University of Oxford
,
MiroBio
Gilead reports 'very strong quarter' despite slipping Veklury sales
Endpoints
Wed, 08/3/22 - 10:55 am
Tags:
Gilead Sciences
,
earnings
,
Biktarvy
Gilead again backs AlloVir's T cell therapy in $127M direct offering
Endpoints
Wed, 07/27/22 - 10:53 am
Tags:
Gilead Sciences
,
AlloVir
,
funding
,
t cell therapy
AIDS 2022 preview – Gilead shoots for an HIV cure
EP Vantage
Wed, 07/27/22 - 10:27 am
Tags:
Gilead Sciences
,
HIV
,
AIDS
Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA's UC and Crohn's draft guidance
Endpoints
Thu, 07/21/22 - 10:38 am
Tags:
Pfizer
,
Gilead Sciences
,
Big Pharma
,
ulcerative colitis
,
Crohn's Disease
,
drug development
,
FDA
Gilead tries again with twice-yearly HIV drug lenacapavir
Pharmaforum
Tue, 06/28/22 - 05:52 pm
Tags:
Gilead Sciences
,
HIV
,
FDA
,
lenacapavir
Gilead nets $33M in settlement over yearslong HIV drug fraud case in Florida
Fierce Pharma
Tue, 06/28/22 - 10:41 am
Tags:
Gilead Sciences
,
HIV
,
fraud
,
Florida
,
legal
Gilead trumpets win for the chronic hepatitis delta prospect it acquired in $1B+ buyout
Fierce Pharma
Thu, 06/23/22 - 07:47 pm
Tags:
Gilead Sciences
,
hepatitis delta
,
Hepcludex
Bristol Myers Squibb takes its CAR-T patent case to US' top court in bid to revive $1.2B verdict against Gilead
Fierce Pharma
Thu, 06/16/22 - 10:48 pm
Tags:
Bristol Myers Squibb
,
Gilead Sciences
,
patents
,
CAR-T
,
Juno Therapeutics
ASCO: Gilead's Trodelvy limps forward in new breast cancer lane as below-par showing casts doubt
Fierce Pharma
Sun, 06/5/22 - 11:42 pm
Tags:
Gilead Sciences
,
Trodelvy
,
breast cancer
,
ASCO 2022
3 cancer drug studies to watch at next month’s ASCO meeting
BioPharma Dive
Thu, 05/26/22 - 10:47 pm
Tags:
ASCO 2022
,
AstraZeneca
,
Enhertu
,
Gilead Sciences
,
Trodelvy
,
Roche
,
tiragolumab
,
cancer
Gilead HIV prospect escapes FDA hold after glass compatibility glitch triggered regulatory setbacks
Fierce Pharma
Tue, 05/17/22 - 10:34 am
Tags:
Gilead Sciences
,
drug manufacturing
,
FDA
,
HIV
,
lenacapavir
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Tags:
Pfizer
,
Biohaven
,
licensing
,
M&A
,
Aurinia
,
Bristol Myers Squibb
,
AbbVie
,
Alector
,
Arcus Biosciences
,
Biogen
,
Blueprint Medicines
,
CureVac
,
Gilead Sciences
,
GSK
,
Incyte
,
MorphoSys
,
Roche
,
Nestle
,
SAGE Therapeutics
,
Sarepta Therapeutics
,
Seres Therapeutics
,
Syndax
The 12 Top Biotech Companies Hiring Now
BioSpace
Tue, 05/10/22 - 10:26 pm
Tags:
biotech
,
life sciences
,
hirings
,
Regeneron
,
Pfizer
,
Amgen
,
AbbVie
,
Moderna Therapeutics
,
CSL Behring
,
Waters Corporation
,
Daiichi Sankyo
,
Gilead Sciences
,
Grail
,
Emergent BioSolutions
,
resilience
Is Gilead Sciences Too Dependent On These 2 Areas of Its Business?
Motley Fool
Sun, 05/8/22 - 12:17 pm
Tags:
Gilead Sciences
,
COVID-19
,
Veklury
,
earnings
,
HIV
'Who wants to make money?' Court documents outline wild fraud scheme targeting Gilead HIV meds
Fierce Pharma
Fri, 05/6/22 - 10:46 am
Tags:
Gilead Sciences
,
legal
,
fraud
,
HIV
,
PrEP
Gilead collects 5th priority review voucher as public advocacy group urged the company to relinquish it
Endpoints
Tue, 05/3/22 - 10:49 am
Tags:
Gilead Sciences
,
COVID-19
,
remdesivir
,
priority review
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.